Campos-Díaz, Aurora http://orcid.org/0000-0002-6213-3410
Morejón-García, Patricia http://orcid.org/0000-0001-5691-5320
Monte-Serrano, Eva http://orcid.org/0000-0002-0865-2244
Ros-Pardo, David
Marcos-Alcalde, Iñigo http://orcid.org/0000-0002-0674-6423
Gómez-Puertas, Paulino http://orcid.org/0000-0003-3131-729X
Lazo, Pedro A. http://orcid.org/0000-0001-8997-3025
Funding for this research was provided by:
Agencia Estatal de Investigación (PID2019-105610RB-I00, PID2022-139598OB-I00, RED2018-102801-T, RTC-2017-6494-1, RTI2018-094434-B-I00)
Consejería de Educación, Junta de Castilla y León (CSI264P20, CLC-2017-01, CSI004-18)
European JPIAMR network “EPIC-Alliance
Ministerio de Universidades (FPU20/02978, FPU16/01883)
Consejo Superior de Investigaciones Cientificas
Article History
Received: 20 November 2023
Revised: 7 March 2024
Accepted: 21 March 2024
First Online: 30 March 2024
Declarations
:
: Does not require ethical approval. Experimental work with established commercial cell lines used to molecularly and functionally characterize pathogenic gene variants.
: The authors declare no competing interests.